CNDO Stock | News | Quote | Stock Forum | Saturday, December

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Coronado Biosciences, Inc. CNDO Company Overview $CNDO

Stock Message Board http://investorshangout.com/search?q=CNDO&...mp;yt1=Go!

Last Updated: Saturday, December 28, 2013 3:10:05 PM

Coronado Biosciences, Inc. CNDO Current Price and Quotes
Last Price 2.75
Previous Close 3.04 Open 3.07
Daily Range 3.15 - 2.70 52wk Range 12.70 - 1.25
Volume 4,900,146 Dividend N/A
Average Vol (3m) 2,169,327 Yield N/A
Coronado Biosciences, Inc. CNDO
Company Information

15 New England Executive Park
Burlington, MA 01803

Website: http://www.coronadobiosciences.com
Phone: 781-238-6621
Email: info@coronadobio.com
Find us on:    

Coronado Biosciences, Inc. CNDO
We are a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of inflammatory diseases and cancer.

Coronado Biosciences, Inc. CNDO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0001429260
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Business Status Development Stage Company a/o Sep 30, 2011
Incorporated In: DE, USA
Year of Inc. 2006
Employees 12 a/o Sep 30, 2011
Service Providers

Auditor/Accountant
PricewaterhouseCoopers
300 Madison Avenue
24th Floor
New York, NY, 10017
United States

Legal Counsel
Loeb & Loeb LLP (NY)
345 Park Avenue
New York, NY, 10154
United States

Investor Relations Firm
Not Available

Coronado Biosciences, Inc. CNDO
CNDO Security Details

Share Structure

Market Value1 $61,252,439 a/o Dec 27, 2013
Shares Outstanding 35,611,883 a/o Oct 30, 2013
Float Not Available
Authorized Shares 50,000,000 a/o Sep 30, 2011
Par Value  0.001
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 0 (-100%)
Dec 30, 2011
Significant Failures to Deliver  No
Transfer Agent(s)

First American Stock Transfer, Inc.

Coronado Biosciences, Inc. CNDO Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 17,468 8,583 8,341 2,270
Sales, General and Admin. 8,665 5,755 900 343
Non-Recurring Items 1,043 20,706 - -
Other - - - -
Operating Income (27,176) (35,044) (9,241) (2,613)
Income From Continuing Operations

Add'l Income/Expense Items 236 (1,242) 794 -
Earnings Before Interest and Tax (26,940) (36,286) (8,447) (2,613)
Interest Expense 670 74 1,535 1,053
Earnings Before Tax (27,610) (36,360) (9,982) (3,666)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (27,610) (36,360) (9,982) (3,666)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (27,610) (36,360) (9,982) (3,666)
Preferred Stock and Other Adjustments - (5,861) - -
Net Income Applicable to Common Shareholders (27,610) (42,221) (9,982) (3,666)

Coronado Biosciences, Inc. CNDO Recent News

Dec 20, 2013 Coronado Biosciences Announces Management Changes
Dec 18, 2013 Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept
Dec 12, 2013 Coronado Biosciences Announces Presentation of Interim Data From Autism Study at Neuropsychopharmacology Meeting
Dec 9, 2013 Coronado Biosciences Announces IND Submission for TSO for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
Nov 7, 2013 Coronado Biosciences Announces Independent Data Monitoring Committee Recommendation to Discontinue Falk Phase 2 Trial of TSO in Crohn's Disease
Nov 6, 2013 Coronado Biosciences Announces Personnel Realignment, Including Appointment of Kevin Horgan, M.D., as Chief Medical Officer
Nov 1, 2013 Coronado Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2013
Oct 15, 2013 TSLA, ARIA, CNDO and AMRN added to NASDAQ Active Stock Watch List at EPR
Oct 14, 2013 BRIEF: Burlington drug firm stock plummets on poor test news
Oct 14, 2013 Coronado Biosciences Announces Top-Line Results From Its TRUST-I Phase 2 Clinical Trial of TSO for the Treatment of Crohn's Disease


CNDO Coronado Biosciences, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CNDO&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CNDO/quote
Stock Chart http://www.otcmarkets.com/stock/CNDO/chart
Company Info http://www.otcmarkets.com/stock/CNDO/company-info
Recent News http://www.otcmarkets.com/stock/CNDO/news
Financials http://www.otcmarkets.com/stock/CNDO/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CNDO/filings
Short Sales http://www.otcmarkets.com/stock/CNDO/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CNDO/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CNDO/research
Summary http://finance.yahoo.com/q?s=CNDO
Historical Prices http://finance.yahoo.com/q/hp?s=CNDO+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CNDO
Basic Chart http://finance.yahoo.com/q/bc?s=CNDO+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CNDO+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CNDO+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CNDO+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CNDO+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CNDO+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CNDO+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CNDO+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CNDO+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CNDO+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CNDO
Balance Sheet http://finance.yahoo.com/q/bs?s=CNDO
Cash Flow http://finance.yahoo.com/q/cf?s=CNDO+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CNDO
Market Watch http://www.marketwatch.com/investing/stock/CNDO
Bloomberg http://www.bloomberg.com/quote/CNDO:US
Morningstar http://quotes.morningstar.com/stock/s?t=CNDO
Bussinessweek http://investing.businessweek.com/research/st...icker=CNDO
Barchart http://www.barchart.com/quotes/stocks/CNDO
OTC Short Report http://otcshortreport.com/index.php?index=CNDO
Investopedia http://www.investopedia.com/markets/stocks/CNDO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 956

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 366

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 98

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Future Leaders: Vantage Partners with AIESEC

Updated Category News Views 285

Vantage as a Platinum Partner of AIESEC FHN Vantage is proud to highlight its inspirational collaboration with AIESEC FHN, a partnership dedicated to empowering youth leadership development. This initiative significantly impacted the career trajectories of numerous young individuals seeking growth within a competitive landscape. The Mission of AIESEC AIESEC stands as a...

Continue Reading
Nicox Reports Strong Q4 2024 Financial Performance and Outlook

Updated Category News Views 140

Nicox Excels in Fourth Quarter Financial Performance Nicox SA, an international ophthalmology company known for its innovative solutions, has unveiled its financial performance for the fourth quarter of 2024. The results reflect the company's resilience and strategic direction as it continues to navigate the complexities of the ophthalmic landscape. Key Financial...

Continue Reading
International Paper's Strategic Move to Acquire DS Smith in Europe

Updated Category News Views 193

International Paper's New Acquisition Strategy International Paper, a prominent player in the packaging industry based in the United States, has recently achieved a significant milestone by receiving the European Union's approval for its acquisition of DS Smith, a UK competitor. This strategic move, valued at approximately $7.2 billion, comes as part of International...

Continue Reading
Market Movements: Futures, Debates and GameStop's Trends

Updated Category News Views 251

Markets Today: Futures, Debate Fallout, and Sector Shifts Stock futures are drifting lower as traders weigh two things at once: upcoming US inflation data and a combative debate between presidential candidates Donald Trump and Kamala Harris. The exchange was lively—lots of heat, fewer specifics—leaving investors still hunting for clear economic plans. Meanwhile,...

Continue Reading
Trogenix Launches Innovative Cancer Treatment Platform to Save Lives

Updated Category News Views 123

Trogenix: A Revolutionary Approach to Cancer Treatment In the rapidly evolving domain of cancer therapies, Trogenix Ltd has emerged with a groundbreaking platform designed to transform cancer treatment, especially for aggressive forms like glioblastoma. Originating from the innovative research of the University of Edinburgh, Trogenix is on a mission to elevate the...

Continue Reading